Quality of life changes over time in patients with chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 22, Issue 2, 2016, Pages 125-129

  Jones, Gary L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

chronic obstructive pulmonary disease; exacerbations; health related quality of life; physical activity level

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; GENERAL CONDITION DETERIORATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH STATUS; HUMAN; PHYSICAL ACTIVITY; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; DYSPNEA; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

CORTICOSTEROID;

ADRENAL CORTEX HORMONES; DISEASE PROGRESSION; DYSPNEA; HUMANS; MOTOR ACTIVITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84957698392     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000242     Document Type: Review

References (42)

1. van der Molen T, Miravitlles M, Kocks JWH. COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis 2013; 8: 461-471.
2. Wheaton AG, Cunningham TJ, Ford ES, et al. Employment and activity limitations among adults with chronic obstructive pulmonary disease-United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64: 289-295.
3. Khakban A, Sin D, Fitzgerald JM, et al. Ten-year trends in direct costs of COPD. Chest 2015; 148: 640-646.
4. Ford ES, Murphy LB, Khavjou O, et al. Total and state-specific medical and absenteeism costs of COPD among adults aged-18 years in the United States for 2010 and projections through 2020. Chest 2015; 147: 31-45.
5. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310: 591-608.
6. Thornton SJ, Romley JA, Wong KS, et al. The disability burden of COPD. COPD 2012; 9: 513-521.
7. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep 2013; 62: 1-96.
8. Meek P, Petersen H, Washko GR, et al. Chronic bronchitis is associated with worse symptoms and quality of life than chronic airflow obstruction. Chest 2015; 148: 408-416.
9. Martinez C, Kim V, Chen V, et al. The clinical impact of nonobstructive chronic bronchitis in current and former smokers. Respir Med 2014; 108: 491-499.
10. Global Initiative for Obstructive Lung Disease, Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease; 2015. http: //www.goldcopd.com. [Accessed 14 October 2015]
11. Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med 2011; 105: 1118-1128.
12. Kim V, Han MK, Vance GB. The chronic bronchitic phenotype of COPD, an analysis of the COPD Gene study. Chest 2011; 140: 626-633.
13. Lange P, Marott JL, Vestbo J. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
14. Nagai K, Makita H, Masaru S, et al. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis 2015; 10: 745-757.
15. Meis JJ, Bosma CB, Spruit MA, et al. A qualitative assessment of COPD patients' experiences of pulmonary rehabilitation and guidance by healthcare professionals. Respir Med 2014; 108: 500-510.
16. Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 s over time in COPD. N Engl J Med 2011; 365: 1184-1192.
17. Lange P, Celli B, Agusti A, et al. Lung function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373: 111-122.
18. Nishimura M, Makita H, Nagai K, et al. Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 44-52.
19. Casanova C, de Torres JP, Aguirre-Jaime A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous, the experience of the BODE cohort. Am J Respir Crit Care Med 2011; 184: 1015-1021.
20. Anzueto A. Review: impact of exacerbations of COPD. Eur Respir Rev 2010; 19: 113-118.
21. Miravitlles M, Garcia-Sidro P, Fernandez-Nistal A, et al. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes 2013; 11: 147-155.
22. Gershon AS, Campitelli MA, Croxford R, et al. Combination long-acting bagonists and inhaled corticosteroids compared with long-acting b-agonists alone in older adults with chronic obstructive pulmonary disease. JAMA 2014; 312: 1114-1121.
23. Yang IA, Clarke MS, Sim EHA, et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 7: CD002991.
24. Lapperre TS, Snoeck-Stroband JB, Gosman MME, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2009; 151: 517-527.
25. Kunz LI, Postma DS, Klooster K, et al. Relapse in FEV1 decline after steroid withdrawal in COPD. Chest 2015; 148: 389-396.
26. Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; 7: CD009285.
27. Jiang YQ, Zhu YX, Chen XL. Impact of adherence to GOLD guidelines on 6-min walk distance, MRC dyspnea scale score, lung function decline, quality of life and quality-adjusted life years in a Shanghai suburb. Genet Mol Res 2015; 14: 8861-8870.
28. National Clinical Guideline Center. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London, UK: National Clinical Guideline Centre; 2010 .
29. McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2: CD03793.
30. Criner GJ, Borbeau J, Diekemper RL, et al. Executive summary, prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 2015; 147: 883-893.
31. Miravitlles M, Cantoni J, Naberan K. Factors associated with a low level of physical activity in patients with chronic obstructive pulmonary disease. Lung 2014; 192: 259-265.
32. Esteban C, Quintana JM, Aburto M, et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010; 36: 292-300.
33. Waschki B, Kirsten AM, Holz O, et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192: 295-306.
34. Bausewein C, Booth S, Gysels M, et al. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 2010; 13: 1109-1118.
35. Weingaertner V, Oek DG, Scheve C, et al. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study. J Pain Symptom Manage 2014; 48: 569-581.
36. Joshi M, Joshi A, Bartter T. Symptom burden in chronic obstructive pulmonary disease and cancer. Curr Opin Pulm Med 2012; 18: 97-103.
37. Habraken JM, van der Wal WM, et al. Health-related quality of life and functional status in end-stage COPD: a longitudinal study. Eur Respir J 2011; 37: 280-288.
38. ViegiG, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013.
39. Murray SA, Kendall M, Boyd K, et al. Illness trajectories and palliative care. BMJ 2005; 330: 1007-1011.
40. Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Respir Care 2004; 49: 90-98.
41. Pinnock H, Kendall M, Murray SA, et al. Living and dying with severe chronic obstructive pulmonary disease: multiperspective longitudinal qualitative study. BMJ 2011; 342: d142.
42. Rocker GM, Simpson C, Horton R. Palliative care in advanced lung disease, the challenge of integrating palliation into everyday care. Chest 2015; 148: 801-809.